{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T06:04:07Z","timestamp":1773468247753,"version":"3.50.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T00:00:00Z","timestamp":1734739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,21]],"date-time":"2024-12-21T00:00:00Z","timestamp":1734739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"DOI":"10.1208\/s12249-024-03007-1","type":"journal-article","created":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T23:58:48Z","timestamp":1734739128000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Amorphous Solid Dispersions of Glycyrrhetinic Acid: Using Soluplus, PVP, and PVPVA as the Polymer Matrix to Enhance Solubility, Bioavailability, and Stability"],"prefix":"10.1208","volume":"26","author":[{"given":"Meng-yu","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xian-bao","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-hua","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ru-xing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian-yu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3989-4219","authenticated-orcid":false,"given":"Pei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,21]]},"reference":[{"key":"3007_CR1","doi-asserted-by":"crossref","first-page":"e609","DOI":"10.1097\/MD.0000000000000609","volume":"94","author":"GQ Zhu","year":"2015","unstructured":"Zhu GQ, Shi KQ, Huang S, Huang GQ, Lin YQ, Zhou ZR, et al. Network meta-analysis of randomized controlled trials: efficacy and safety of UDCA-based therapies in primary biliary cirrhosis. Med (Baltimore). 2015;94:e609.","journal-title":"Med (Baltimore)"},{"key":"3007_CR2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11864-015-0338-4","volume":"16","author":"K Noriyuki","year":"2015","unstructured":"Noriyuki K. Dose-dense approaches to ovarian cancer treatment. Curr Treat Options Oncol. 2015;16:21.","journal-title":"Curr Treat Options Oncol"},{"issue":"1","key":"3007_CR3","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/CAD.0000000000000159","volume":"26","author":"G Arpino","year":"2015","unstructured":"Arpino G, De Placido S, De Angelis C. Nab-paclitaxel for the management of triple-negative metastatic breast cancer: a case study. Anticancer Drugs. 2015;26(1):117\u201322.","journal-title":"Anticancer Drugs"},{"issue":"1","key":"3007_CR4","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1208\/s12249-016-0497-z","volume":"18","author":"P Tang","year":"2017","unstructured":"Tang P, Wang L, Ma X, Xu K, Xiong X, Liao X, et al. Characterization and In Vitro Evaluation of the Complexes of Posaconazole with \u03b2- and 2,6-di-O-methyl-\u03b2-cyclodextrin. AAPS PharmSciTech. 2017;18(1):104\u201314.","journal-title":"AAPS PharmSciTech"},{"issue":"7","key":"3007_CR5","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1208\/s12249-023-02662-0","volume":"24","author":"J Halder","year":"2023","unstructured":"Halder J, Mahanty R, Rajwar TK, Rai VK, Kar B, Ghosh G, et al. Nanofibers of Glycyrrhizin\/Hydroxypropyl-\u03b2-Cyclodextrin Inclusion Complex: Enhanced Solubility Profile and Anti-inflammatory Effect of Glycyrrhizin. AAPS PharmSciTech. 2023;24(7):196.","journal-title":"AAPS PharmSciTech"},{"issue":"8","key":"3007_CR6","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1208\/s12249-023-02687-5","volume":"24","author":"W Chaisri","year":"2023","unstructured":"Chaisri W, Suebsakwong P, Pandith H, Panya A, Taynawa K, Pikulkaew S, et al. Effects of Encapsulation of Caesalpinia sappan L. with Cyclodextrins for Bovine Mastitis. AAPS PharmSciTech. 2023;24(8):230.","journal-title":"AAPS PharmSciTech"},{"issue":"7","key":"3007_CR7","doi-asserted-by":"crossref","first-page":"e202200672","DOI":"10.1002\/cbic.202200672","volume":"24","author":"S Sarkar","year":"2023","unstructured":"Sarkar S, Ekbal Kabir M, Kalita J, Manna P. Mesoporous Silica Nanoparticles: Drug Delivery Vehicles for Antidiabetic Molecules. ChemBioChem. 2023;24(7):e202200672.","journal-title":"ChemBioChem"},{"key":"3007_CR8","doi-asserted-by":"crossref","first-page":"106015","DOI":"10.1016\/j.ejps.2021.106015","volume":"167","author":"A Baumgartner","year":"2021","unstructured":"Baumgartner A, Planin\u0161ek O. Application of commercially available mesoporous silica for drug dissolution enhancement in oral drug delivery. Eur J Pharm Sci. 2021;167:106015.","journal-title":"Eur J Pharm Sci"},{"issue":"7","key":"3007_CR9","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1208\/s12249-022-02408-4","volume":"23","author":"AG Nambiar","year":"2022","unstructured":"Nambiar AG, Singh M, Mali AR, Serrano DR, Kumar R, Healy AM, et al. Continuous Manufacturing and Molecular Modeling of Pharmaceutical Amorphous Solid Dispersions. AAPS PharmSciTech. 2022;23(7):249.","journal-title":"AAPS PharmSciTech"},{"key":"3007_CR10","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1080\/17460441.2023.2211801","volume":"18","author":"B Rocha","year":"2023","unstructured":"Rocha B, de Morais LA, Viana MC, Carneiro G. Promising strategies for improving oral bioavailability of poor water-soluble drugs. Expert Opin Drug Discov. 2023;18:615\u201327.","journal-title":"Expert Opin Drug Discov"},{"issue":"1","key":"3007_CR11","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s11095-023-03632-8","volume":"41","author":"R He","year":"2024","unstructured":"He R, Lamm MS, Brunskill A, Axnanda S, Li Y. Impact of Processing Methods on the Physico-chemical Properties of Posaconazole Amorphous Solid Dispersions. Pharm Res. 2024;41(1):141\u201351.","journal-title":"Pharm Res"},{"key":"3007_CR12","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1021\/mp5006245","volume":"12","author":"J Chen","year":"2015","unstructured":"Chen J, Ormes JD, Higgins JD, Taylor LS. Impact of surfactants on the crystallization of aqueous suspensions of celecoxib amorphous solid dispersion spray dried particles. Mol Pharm. 2015;12:533\u201341.","journal-title":"Mol Pharm"},{"issue":"9","key":"3007_CR13","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1016\/j.xphs.2015.10.008","volume":"105","author":"S Baghel","year":"2016","unstructured":"Baghel S, Cathcart H, O\u2019Reilly NJ. Polymeric Amorphous Solid Dispersions: A Review of Amorphization, Crystallization, Stabilization, Solid-State Characterization, and Aqueous Solubilization of Biopharmaceutical Classification System Class II Drugs. J Pharm Sci. 2016;105(9):2527\u201344.","journal-title":"J Pharm Sci"},{"key":"3007_CR14","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jconrel.2018.04.014","volume":"279","author":"N Li","year":"2018","unstructured":"Li N, Taylor LS. Tailoring supersaturation from amorphous solid dispersions. J Control Release. 2018;279:114\u201325.","journal-title":"J Control Release"},{"key":"3007_CR15","doi-asserted-by":"crossref","first-page":"121498","DOI":"10.1016\/j.ijpharm.2022.121498","volume":"615","author":"MT Fran\u00e7a","year":"2022","unstructured":"Fran\u00e7a MT, Martins Marcos T, Costa PFA, Bazzo GC, Nicolay Pereira R, Gerola AP, et al. Eutectic mixture and amorphous solid dispersion: Two different supersaturating drug delivery system strategies to improve griseofulvin release using saccharin. Int J Pharm. 2022;615:121498.","journal-title":"Int J Pharm"},{"issue":"6","key":"3007_CR16","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1080\/17425247.2017.1230099","volume":"14","author":"K Kawakami","year":"2017","unstructured":"Kawakami K. Supersaturation and crystallization: non-equilibrium dynamics of amorphous solid dispersions for oral drug delivery. Expert Opin Drug Deliv. 2017;14(6):735\u201343.","journal-title":"Expert Opin Drug Deliv"},{"issue":"1","key":"3007_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2017.08.123","volume":"532","author":"R Laitinen","year":"2017","unstructured":"Laitinen R, L\u00f6bmann K, Grohganz H, Priemel P, Strachan CJ, Rades T. Supersaturating drug delivery systems: The potential of co-amorphous drug formulations. Int J Pharm. 2017;532(1):1\u201312.","journal-title":"Int J Pharm"},{"key":"3007_CR18","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ejpb.2021.05.030","volume":"166","author":"YW Li","year":"2021","unstructured":"Li YW, Zhang HM, Cui BJ, Hao CY, Zhu HY, Guan J, et al. \u201cFelodipine-indomethacin\u201d co-amorphous supersaturating drug delivery systems: \u201cSpring-parachute\u201d process, stability, in vivo bioavailability, and underlying molecular mechanisms. Eur J Pharm Biopharm. 2021;166:111\u201325.","journal-title":"Eur J Pharm Biopharm"},{"key":"3007_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/03639045.2021.1879843","volume":"47","author":"P Ashwathy","year":"2021","unstructured":"Ashwathy P, Anto Akshaya T, Sudheesh MS. A mechanistic review on the dissolution phase behavior and supersaturation stabilization of amorphous solid dispersions. Drug Dev Ind Pharm. 2021;47:1\u201311.","journal-title":"Drug Dev Ind Pharm"},{"key":"3007_CR20","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.ijpharm.2019.06.010","volume":"566","author":"J Guan","year":"2019","unstructured":"Guan J, Huan X, Liu Q, Jin L, Wu H, Zhang X, et al. Synergetic effect of nucleation and crystal growth inhibitor on in vitro-in vivo performance of supersaturable lacidipine solid dispersion. Int J Pharm. 2019;566:594\u2013603.","journal-title":"Int J Pharm"},{"key":"3007_CR21","doi-asserted-by":"crossref","first-page":"123504","DOI":"10.1016\/j.ijpharm.2023.123504","volume":"647","author":"T Kojima","year":"2023","unstructured":"Kojima T, Takeda J, Song Y, Yamamoto K, Ikeda Y. Polymer-inducing chemical degradation of amorphous solid dispersions driven by drug-polymer interactions for physical stabilization. Int J Pharm. 2023;647:123504.","journal-title":"Int J Pharm"},{"key":"3007_CR22","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1208\/s12249-020-01849-z","volume":"21","author":"AR Nair","year":"2020","unstructured":"Nair AR, Lakshman YD, Anand VSK, Sree KSN, Bhat K, Dengale SJ. Overview of Extensively Employed Polymeric Carriers in Solid Dispersion Technology. AAPS PharmSciTech. 2020;21:309.","journal-title":"AAPS PharmSciTech"},{"key":"3007_CR23","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ejpb.2023.09.008","volume":"191","author":"L Louis","year":"2023","unstructured":"Louis L, Chee BS, McAfee M, Nugent MJD. Design, development and in vitro quantification of novel electrosprayed everolimus-loaded Soluplus\u00ae\/Polyvinyl alcohol nanoparticles via stability-indicating HPLC method in cancer therapy. Eur J Pharm Biopharm. 2023;191:235\u201346.","journal-title":"Eur J Pharm Biopharm"},{"issue":"10","key":"3007_CR24","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.3390\/pharmaceutics14102203","volume":"14","author":"S Tambe","year":"2022","unstructured":"Tambe S, Jain D, Meruva SK, Rongala G, Juluri A, Nihalani G, et al. Recent Advances in Amorphous Solid Dispersions: Preformulation, Formulation Strategies, Technological Advancements and Characterization. Pharmaceutics. 2022;14(10):2203.","journal-title":"Pharmaceutics"},{"issue":"8","key":"3007_CR25","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.3390\/pharmaceutics14081747","volume":"14","author":"Q Shi","year":"2022","unstructured":"Shi Q, Chen H, Wang Y, Wang R, Xu J, Zhang C. Amorphous Solid Dispersions: Role of the Polymer and Its Importance in Physical Stability and In Vitro Performance. Pharmaceutics. 2022;14(8):1747.","journal-title":"Pharmaceutics"},{"key":"3007_CR26","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ejpb.2019.09.005","volume":"144","author":"E Boel","year":"2019","unstructured":"Boel E, Smeets A, Vergaelen M, De la Rosa VR, Hoogenboom R, Van den Mooter G. Comparative study of the potential of poly(2-ethyl-2-oxazoline) as carrier in the formulation of amorphous solid dispersions of poorly soluble drugs. Eur J Pharm Biopharm. 2019;144:79\u201390.","journal-title":"Eur J Pharm Biopharm"},{"key":"3007_CR27","doi-asserted-by":"crossref","first-page":"105262","DOI":"10.1016\/j.ejps.2020.105262","volume":"146","author":"R Peng","year":"2020","unstructured":"Peng R, Huang J, He L, Zhao L, Wang C, Wei W, et al. Polymer\/lipid interplay in altering in vitro supersaturation and plasma concentration of a model poorly soluble drug. Eur J Pharm Sci. 2020;146:105262.","journal-title":"Eur J Pharm Sci"},{"issue":"4","key":"3007_CR28","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.3390\/pharmaceutics15041231","volume":"15","author":"N Rosiak","year":"2023","unstructured":"Rosiak N, Tykarska E, Cielecka-Piontek J. Amorphous Pterostilbene Delivery Systems Preparation-Innovative Approach to Preparation Optimization. Pharmaceutics. 2023;15(4):1231.","journal-title":"Pharmaceutics"},{"key":"3007_CR29","doi-asserted-by":"publisher","unstructured":"Graebin CS. The Pharmacological Activities of Glycyrrhizinic Acid (\u201cGlycyrrhizin\u201d) and Glycyrrhetinic Acid. In: M\u00e9rillon JM, Ramawat K editors. Sweeteners. Reference Series in Phytochemistry. Cham, Springer; 2018. https:\/\/doi.org\/10.1007\/978-3-319-27027-2_15","DOI":"10.1007\/978-3-319-27027-2_15"},{"key":"3007_CR30","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12979-023-00337-9","volume":"20","author":"X Gong","year":"2023","unstructured":"Gong X, Shen H, Guo L, Huang C, Su T, Wang H, et al. Glycyrrhizic acid inhibits myeloid differentiation of hematopoietic stem cells by binding S100 calcium binding protein A8 to improve cognition in aged mice. Immun Ageing. 2023;20:12.","journal-title":"Immun Ageing"},{"key":"3007_CR31","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1016\/S0140-6736(03)13615-X","volume":"361","author":"J Cinatl","year":"2003","unstructured":"Cinatl J, Morgenstern B, Bauer G, Chandra P, Rabenau H, Doerr HW. Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus. Lancet. 2003;361:2045\u20136.","journal-title":"Lancet"},{"key":"3007_CR32","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1016\/j.bmcl.2015.02.074","volume":"25","author":"LA Baltina","year":"2015","unstructured":"Baltina LA, Zarubaev VV, Baltina LA, Orshanskaya IA, Fairushina AI, Kiselev OI, et al. Glycyrrhizic acid derivatives as influenza A\/H1N1 virus inhibitors. Bioorg Med Chem Lett. 2015;25:1742\u20136.","journal-title":"Bioorg Med Chem Lett"},{"key":"3007_CR33","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1002\/jmv.26064","volume":"92","author":"H Ding","year":"2020","unstructured":"Ding H, Deng W, Ding L, Ye X, Yin S, Huang W. Glycyrrhetinic acid and its derivatives as potential alternative medicine to relieve symptoms in nonhospitalized COVID-19 patients. J Med Virol. 2020;92:2200\u20134.","journal-title":"J Med Virol"},{"key":"3007_CR34","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.3389\/fimmu.2020.01239","volume":"11","author":"H Murck","year":"2020","unstructured":"Murck H. Symptomatic Protective Action of Glycyrrhizin (Licorice) in COVID-19 Infection? Front Immunol. 2020;11:1239.","journal-title":"Front Immunol"},{"key":"3007_CR35","unstructured":"Pan F. Intervention effect of glycyrrhetinic acid solid dispersion on liver injury in rats exposed to cadmium (Master's thesis, North China University of Science and Technology). Master's degree.\u00a02015. https:\/\/kns.cnki.net\/kcms2\/article\/abstract?v=ifIT5_n5_Gf9VJUFrm-rgXKyeFuvpj6WJhvCvdOTp9xauxH8WLCHhgksw5dtF49aVjaDUWRP0m4lChbp5Q4GFOoEZztFRmWTZVz9TyR31cYISILQ1eRG4xwBaGFA7TOuTfWyt9kr36i4Hvt9W-0PcUZugKf-SmRu-FQrYhWnjpmisESNLZXxjZNVfzvfvcjm4gggDmdjVEE=&uniplatform=NZKPT&language=CHS."},{"issue":"14","key":"3007_CR36","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.3390\/polym15143034","volume":"15","author":"A Budiman","year":"2023","unstructured":"Budiman A, Nurani NV, Laelasari E, Muchtaridi M, Sriwidodo S, Aulifa DL. Effect of Drug-Polymer Interaction in Amorphous Solid Dispersion on the Physical Stability and Dissolution of Drugs: The Case of Alpha-Mangostin. Polymers (Basel). 2023;15(14):3034.","journal-title":"Polymers (Basel)"},{"key":"3007_CR37","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.2147\/DDDT.S253405","volume":"14","author":"P Liu","year":"2020","unstructured":"Liu P, Zhou JY, Chang JH, Liu XG, Xue HF, Wang RX, et al. Soluplus-Mediated Diosgenin Amorphous Solid Dispersion with High Solubility and High Stability: Development, Characterization and Oral Bioavailability. Drug Des Devel Ther. 2020;14:2959\u201375.","journal-title":"Drug Des Devel Ther"},{"issue":"9","key":"3007_CR38","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1016\/j.xphs.2022.04.002","volume":"111","author":"VK Seiler","year":"2022","unstructured":"Seiler VK, Theil F, Nagel N, van Lishaut H. Adding a New Dimension to the Amorphous Solid Dispersion Phase Diagram: Studying Dissolution Kinetics of Crystalline Drugs in a Polymer Matrix Using Temperature Dependent XRPD and DSC. J Pharm Sci. 2022;111(9):2496\u2013504.","journal-title":"J Pharm Sci"},{"key":"3007_CR39","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1208\/s12249-021-02036-4","volume":"22","author":"C Lim","year":"2021","unstructured":"Lim C, Kang JK, Jung CE, Sim T, Her J, Kang K, et al. Preparation and Characterization of a Lutein Solid Dispersion to Improve Its Solubility and Stability. AAPS PharmSciTech. 2021;22:169.","journal-title":"AAPS PharmSciTech"},{"key":"3007_CR40","doi-asserted-by":"crossref","first-page":"121532","DOI":"10.1016\/j.ijpharm.2022.121532","volume":"616","author":"NG Patel","year":"2022","unstructured":"Patel NG, Serajuddin ATM. Moisture sorption by polymeric excipients commonly used in amorphous solid dispersion and its effect on glass transition temperature: I. Polyvinylpyrrolidone and related copolymers. Int J Pharm. 2022;616:121532.","journal-title":"Int J Pharm"},{"key":"3007_CR41","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1021\/acs.molpharmaceut.2c00695","volume":"20","author":"D Gao","year":"2023","unstructured":"Gao D, Zhu D, Zhou X, Dong S, Chen Y. Inhomogeneous Phase Significantly Reduces Oral Bioavailability of Felodipine\/PVPVA Amorphous Solid Dispersion. Mol Pharm. 2023;20:409\u201318.","journal-title":"Mol Pharm"},{"key":"3007_CR42","doi-asserted-by":"crossref","first-page":"106086","DOI":"10.1016\/j.ejps.2021.106086","volume":"169","author":"D Yu","year":"2022","unstructured":"Yu D, Li J, Wang H, Pan H, Li T, Bu T, et al. Role of polymers in the physical and chemical stability of amorphous solid dispersion: A case study of carbamazepine. Eur J Pharm Sci. 2022;169:106086.","journal-title":"Eur J Pharm Sci"},{"key":"3007_CR43","first-page":"95","volume":"14","author":"Z Wang","year":"2019","unstructured":"Wang Z, Sun M, Liu T, Gao Z, Ye Q, Tan X, et al. Co-amorphous solid dispersion systems of lacidipine-spironolactone with improved dissolution rate and enhanced physical stability. Asian J Pharm Sci. 2019;14:95\u2013103.","journal-title":"Asian J Pharm Sci"},{"issue":"1","key":"3007_CR44","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3390\/pharmaceutics12010082","volume":"12","author":"L Dong","year":"2020","unstructured":"Dong L, Mai Y, Liu Q, Zhang W, Yang J. Mechanism and Improved Dissolution of Glycyrrhetinic Acid Solid Dispersion by Alkalizers. Pharmaceutics. 2020;12(1):82.","journal-title":"Pharmaceutics"},{"key":"3007_CR45","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ijpharm.2014.02.004","volume":"465","author":"Y Lu","year":"2014","unstructured":"Lu Y, Tang N, Lian R, Qi J, Wu W. Understanding the relationship between wettability and dissolution of solid dispersion. Int J Pharm. 2014;465:25\u201331.","journal-title":"Int J Pharm"},{"key":"3007_CR46","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1208\/s12249-022-02413-7","volume":"23","author":"D Yu","year":"2022","unstructured":"Yu D, Fiddler F, Ibrahim A, Sanedrin R, Tremblay H, Hoag SW. Surface Characterization as a Tool for Identifying the Factors Affecting the Dissolution Rate of Amorphous Solid Dispersion Tablets. AAPS PharmSciTech. 2022;23:282.","journal-title":"AAPS PharmSciTech"},{"key":"3007_CR47","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.ejpb.2008.05.026","volume":"70","author":"C Dahlberg","year":"2008","unstructured":"Dahlberg C, Millqvist-Fureby A, Schuleit M. Surface composition and contact angle relationships for differently prepared solid dispersions. Eur J Pharm Biopharm. 2008;70:478\u201385.","journal-title":"Eur J Pharm Biopharm"},{"key":"3007_CR48","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ijpharm.2019.01.038","volume":"559","author":"M Alshafiee","year":"2019","unstructured":"Alshafiee M, Aljammal MK, Markl D, Ward A, Walton K, Blunt L, et al. Hot-melt extrusion process impact on polymer choice of glyburide solid dispersions: The effect of wettability and dissolution. Int J Pharm. 2019;559:245\u201354.","journal-title":"Int J Pharm"},{"issue":"211","key":"3007_CR49","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jconrel.2015.06.004","volume":"10","author":"DD Sun","year":"2015","unstructured":"Sun DD, Lee PI. Probing the mechanisms of drug release from amorphous solid dispersions in medium-soluble and medium-insoluble carriers. J Control Release. 2015;10(211):85\u201393.","journal-title":"J Control Release"},{"issue":"9","key":"3007_CR50","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1021\/acs.molpharmaceut.1c00419","volume":"18","author":"C Que","year":"2021","unstructured":"Que C, Deac A, Zemlyanov DY, Qi Q, Indulkar AS, Gao Y, et al. Impact of Drug-Polymer Intermolecular Interactions on Dissolution Performance of Copovidone-Based Amorphous Solid Dispersions. Mol Pharm. 2021;18(9):3496\u2013508.","journal-title":"Mol Pharm"},{"key":"3007_CR51","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1016\/j.apsb.2021.05.014","volume":"11","author":"SV Bhujbal","year":"2021","unstructured":"Bhujbal SV, Mitra B, Jain U, Gong Y, Agrawal A, Karki S, et al. Pharmaceutical amorphous solid dispersion: A review of manufacturing strategies. Acta Pharm Sin B. 2021;11:2505\u201336.","journal-title":"Acta Pharm Sin B"},{"issue":"188","key":"3007_CR52","doi-asserted-by":"crossref","first-page":"106513","DOI":"10.1016\/j.ejps.2023.106513","volume":"1","author":"PD Nunes","year":"2023","unstructured":"Nunes PD, Ferreira AF, Pinto JF, Bauer-Brandl A, Brandl M, Henriques J, et al. In vitro dissolution\/permeation tools for amorphous solid dispersions bioavailability forecasting II: Comparison and mechanistic insights. Eur J Pharm Sci. 2023;1(188):106513.","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"3007_CR53","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1186\/1556-276X-9-684","volume":"9","author":"L Dian","year":"2014","unstructured":"Dian L, Yu E, Chen X, Wen X, Zhang Z, Qin L, et al. Enhancing oral bioavailability of quercetin using novel soluplus polymeric micelles. Nanoscale Res Lett. 2014;9(1):2406.","journal-title":"Nanoscale Res Lett"},{"issue":"1","key":"3007_CR54","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1080\/10717544.2020.1785582","volume":"27","author":"G Li","year":"2020","unstructured":"Li G, Lu Y, Fan Y, Ning Q, Li W. Enhanced oral bioavailability of magnolol via mixed micelles and nanosuspensions based on Soluplus\u00ae-Poloxamer 188. Drug Deliv. 2020;27(1):1010\u20137.","journal-title":"Drug Deliv"},{"issue":"134","key":"3007_CR55","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ejps.2019.04.022","volume":"15","author":"P Zi","year":"2019","unstructured":"Zi P, Zhang C, Ju C, Su Z, Bao Y, Gao J, et al. Solubility and bioavailability enhancement study of lopinavir solid dispersion matrixed with a polymeric surfactant - Soluplus. Eur J Pharm Sci. 2019;15(134):233\u201345.","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"3007_CR56","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ijpharm.2017.09.005","volume":"532","author":"AS Deshmukh","year":"2017","unstructured":"Deshmukh AS, Chauhan PN, Noolvi MN, Chaturvedi K, Ganguly K, Shukla SS, et al. Polymeric micelles: Basic research to clinical practice. Int J Pharm. 2017;532(1):249\u201368.","journal-title":"Int J Pharm"},{"key":"3007_CR57","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.addr.2016.01.012","volume":"100","author":"T Vasconcelos","year":"2016","unstructured":"Vasconcelos T, Marques S, dasNevesSarmento JB. Amorphous solid dispersions: Rational selection of a manufacturing process. Adv Drug Deliv Rev. 2016;100:85\u2013101.","journal-title":"Adv Drug Deliv Rev"},{"issue":"4","key":"3007_CR58","doi-asserted-by":"crossref","first-page":"650","DOI":"10.3109\/03639045.2014.891131","volume":"41","author":"HF Mansour","year":"2015","unstructured":"Mansour HF, Aly UF. In vitro evaluation and in vivo performance of lyophilized gliclazide. Drug Dev Ind Pharm. 2015;41(4):650\u20137.","journal-title":"Drug Dev Ind Pharm"},{"issue":"5","key":"3007_CR59","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1208\/s12249-016-0642-8","volume":"18","author":"Z Lu","year":"2017","unstructured":"Lu Z, Yang Y, Covington RA, Bi YV, D\u00fcrig T, Fassihi R. Amorphous-based controlled-release gliclazide matrix system. AAPS PharmSciTech. 2017;18(5):1699\u2013709.","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"3007_CR60","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s12272-013-0012-y","volume":"36","author":"TH Tran","year":"2013","unstructured":"Tran TH, Poudel BK, Marasini N, Woo JS, Choi HG, Yong CS, et al. Development of raloxifene-solid dispersion with improved oral bioavailability via spray-drying technique. Arch Pharm Res. 2013;36(1):86\u201393.","journal-title":"Arch Pharm Res"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-024-03007-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12249-024-03007-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-024-03007-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T19:28:32Z","timestamp":1739993312000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12249-024-03007-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,21]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["3007"],"URL":"https:\/\/doi.org\/10.1208\/s12249-024-03007-1","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,21]]},"assertion":[{"value":"1 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal study was reviewed and approved by Animal Ethics Committee of Chengde Medical University. (Approval No. CDMULAC-20190502\u2013019).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Statement"}},{"value":"The authors declare no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}}],"article-number":"18"}}